Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 601–625 of 7,816 matching trials · page 25 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
A Study to Evaluate the Efficacy and Safety of TTYP01 Tablets in Early Symptomatic Alzheimer's Disease NCT07252440 TTYP01 tables 60mg; TTYP01 tables 90mg; TTYP01 tables 0mg Runs in: China · 1 site |
PHASE2 other |
RECRUITING | 180 | Shanghai Auzone Biological Technology Co., Ltd. INDUSTRY |
2026-07-16 |
|
A Study Of Phototherapy In Patients With Dementia To Improve BPSD NCT07488195 Phototherapy Runs in: United States · 1 site |
NA other |
NOT_YET_RECRUITING | 70 | Mayo Clinic OTHER |
2026-07-16 |
|
Investigating the Effectiveness of Personalized Optimal Gamma Auditory Frequency Stimulation Intervention on Cognitive Function Enhancement NCT07690865 Personalized optimal gamma auditory frequency stimulation; Non-opti... Runs in: Taiwan · 1 site |
NA other |
NOT_YET_RECRUITING | 20 | Chang Gung Memorial Hospital OTHER |
2026-07-16 |
|
Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease - EU NCT07708675 Symani Surgical System |
NA other |
NOT_YET_RECRUITING | 50 | MMI (Medical Microinstruments, Inc.) INDUSTRY |
2026-07-16 |
|
Interventions for Patients With Alzheimer's Disease and Dysphagia NCT03682081 Isometric tongue strengthening facilitated by Iowa Oral Performance... Runs in: United States · 1 site |
NA other |
COMPLETED | 76 | University of Wisconsin, Madison OTHER |
2026-07-15 |
|
Effects of Electrical Stimulation on Verbal Learning in Typical and Atypical Alzheimer's Disease NCT04122001 Active, in-person HD-tDCS or active remote tDCS; Sham; Word List Le... Runs in: United States · 1 site |
NA other |
ACTIVE_NOT_RECRUITING | 90 | Johns Hopkins University OTHER |
2026-07-15 |
|
PRIMA Intervention for Adults With Mild Cognitive Impairment and Their Caregivers NCT04515875 Daily Engagement Meaningful Activity (DEMA); Information Support (IS) Runs in: United States · 1 site |
NA other |
COMPLETED | 420 | Indiana University OTHER |
2026-07-15 |
|
Online Insomnia Intervention to Reduce Alcohol Use NCT05630118 SHUTi Intervention; Web-Based Insomnia Education Program Runs in: United States · 1 site |
NA other |
COMPLETED | 113 | Jessica Weafer OTHER |
2026-07-15 |
|
Brain Health Virtual Reality Study NCT06124339 Physical Activity; Cognitive Activity (VR); Physical and Cognitive Activity Runs in: United States · 1 site |
NA other |
ACTIVE_NOT_RECRUITING | 150 | University of California, San Diego OTHER |
2026-07-15 |
|
A Feasiblity Study of Green Activity Program for People Living With Memory Challenges NCT06403345 Green Activity Program Runs in: United States · 1 site |
NA other |
RECRUITING | 40 | Indiana University OTHER |
2026-07-15 |
|
Modifiable Risk Factors for Cognitive Dysfunction in Patients With Coronary Heart Disease NCT07657624 Runs in: China · 1 site |
NA other |
RECRUITING | 2,352 | Beijing Anzhen Hospital OTHER |
2026-07-15 |
|
Individual Closed-Loop Neuromodulation Therapy for Alzheimer's Disease NCT05904132 tACS device Runs in: United States · 1 site |
NA other |
RECRUITING | 70 | Massachusetts General Hospital OTHER |
2026-07-14 |
|
Brain Health in Midlife NCT06640842 A combination of various tests and biomarkers will be completed to ... Runs in: United States · 1 site |
NA other |
COMPLETED | 24 | University of Kansas Medical Center OTHER |
2026-07-14 |
|
Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV NCT06705478 Pramipexole ER; Escitalopram Runs in: Botswana; Brazil; India; Kenya; Malawi; Mexico; Peru; Phi... · 41 sites |
PHASE2 other |
SUSPENDED | 186 | National Institute of Allergy and Infectious Diseases (NIAID) NIH |
2026-07-14 |
|
Mexidol® Efficacy and Safety in Treatment of VCIND in Older Adults NCT07700615 Mexidol; Standard Therapy Runs in: Russia · 4 sites |
PHASE4 other |
COMPLETED | 120 | Pharmasoft INDUSTRY |
2026-07-14 |
|
Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device NCT07701161 Runs in: United States · 5 sites |
NA other |
RECRUITING | 1,000 | Neurogen Biomarking LLC INDUSTRY |
2026-07-14 |
|
Superior Parietal iTBS for PD-MCI NCT07701785 Accelerated intermittent theta-burst stimulation (iTBS) rTMS to rig... Runs in: United States · 1 site |
NA other |
RECRUITING | 30 | Medical University of South Carolina OTHER |
2026-07-14 |
|
Non-pharmacological Interventions for People With Mild Cognitive Impairment in the Community NCT07703267 Community-Family Mutual Support Intervention; Routine Community Care |
NA other |
NOT_YET_RECRUITING | 70 | Anhui Medical University OTHER |
2026-07-14 |
|
Self-consciousness in Dementia NCT01782248 Questionnary and IRM Runs in: France · 1 site |
NA other |
TERMINATED | 40 | University Hospital, Strasbourg, France OTHER |
2026-07-13 |
|
Light, Metabolic Syndrome and Alzheimer's Disease - Aim 2 NCT03933696 Tailored Lighting Intervention Runs in: United States · 2 sites |
NA other |
COMPLETED | 25 | Icahn School of Medicine at Mount Sinai OTHER |
2026-07-13 |
|
Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X) NCT04601038 CORT108297; Placebo Runs in: United States · 1 site |
PHASE2 other |
RECRUITING | 52 | Johns Hopkins University OTHER |
2026-07-13 |
|
Sleep Trial to Prevent Alzheimer's Disease NCT04629547 Suvorexant 20 mg; Placebo Runs in: United States · 1 site |
PHASE2 other |
RECRUITING | 120 | University of Minnesota OTHER |
2026-07-13 |
|
Evaluate the Effect of Atorvastatin on Cerebrovascular Reactivity in Mild Cognitive Impairment (MCI) NCT04765137 Atorvastatin Oral Tablet Runs in: United States · 1 site |
PHASE2 other |
RECRUITING | 20 | Johns Hopkins University OTHER |
2026-07-13 |
|
CBT-I vs. MBTI for Traumatic Brain Injury (TBI)-Related Insomnia and Post-Traumatic Stress Symptoms NCT05663034 Mindfulness-based treatment for insomnia (MBTI); Cognitive behavior... Runs in: United States · 5 sites |
NA other |
RECRUITING | 360 | Johns Hopkins University OTHER |
2026-07-13 |
|
DORA and LP in Alzheimer's Disease Biomarkers NCT06274528 Lemborexant 10 mg; Lemborexant 20mg; Placebo Runs in: United States · 1 site |
PHASE2 other |
RECRUITING | 201 | University of Minnesota OTHER |
2026-07-13 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial